FDA Reform Bill Goes Back To The Future In House With Tighter Safety Rules
This article was originally published in The Tan Sheet
Executive Summary
The discussion drafts of the FDA reform legislation being circulated by the House Energy and Commerce Committee contain many provisions that were removed during debate in Senate
You may also be interested in...
Federal Pre-emption Defense Under Fire In Draft House Bills
A one-sentence provision tucked into draft House legislation renewing FDA's drug user fee program seeks to weaken manufacturers' ability to use FDA approval as a defense in state product liability lawsuits
Federal Pre-emption Defense Under Fire In Draft House Bills
A one-sentence provision tucked into draft House legislation renewing FDA's drug user fee program seeks to weaken manufacturers' ability to use FDA approval as a defense in state product liability lawsuits
Federal Pre-emption Defense Under Fire In Draft House Bills
A one-sentence provision tucked into draft House legislation renewing FDA's drug user fee program seeks to weaken manufacturers' ability to use FDA approval as a defense in state product liability lawsuits
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: